Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial Fibrillation in Infiltrative Cardiomyopathies: From Atrial Cardiomyopathy Imaging to Targeted Management-A Narrative Review.

Medicina (Kaunas, Lithuania)·2026
Same author

Robot-assisted surgery for Hirschsprung disease in children: initial single-center experience.

Frontiers in surgery·2026
Same author

Standardization of Nasal Cytology: An Expert-based Delphi Consensus.

Current allergy and asthma reports·2026
Same author

A Metabolites' Interplay Can Modulate DNA Repair by Homologous Recombination.

International journal of molecular sciences·2026
Same author

Evolutionary constraints on anuran melanin for 45 million years.

iScience·2026
Same author

Updating the Role of Carboplatin Added to Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis.

Cancers·2025

Related Experiment Video

Updated: May 31, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

The atorvastatin during ischemic stroke study: a pilot randomized controlled trial.

Antonio Muscari1, Giovanni M Puddu, Nadia Santoro

  • 1Department of Internal Medicine, Aging and Nephrological Diseases-Stroke Unit, University of Bologna and S.Orsola-Malpighi Hospital, Bologna, Italy. antonio.muscari@unibo.it

Clinical Neuropharmacology
|June 17, 2011
PubMed
Summary
This summary is machine-generated.

High-dose atorvastatin showed no short-term benefit for acute ischemic stroke patients. However, it suggested a possible functional improvement at three months for mild stroke cases, warranting further research.

Related Experiment Videos

Last Updated: May 31, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statins possess pleiotropic effects, including antioxidant and anti-inflammatory properties.
  • These properties suggest a potential therapeutic role for statins in the acute phase of ischemic stroke.

Purpose of the Study:

  • To assess the neuroprotective effects of high-dose atorvastatin in the early phase of ischemic stroke.
  • To gather preliminary data for a larger multicenter trial.

Main Methods:

  • A pilot, double-blind, randomized controlled trial involving 62 ischemic stroke patients.
  • Patients received either atorvastatin 80 mg/d or placebo for 7 days.
  • Primary endpoint: ≥4-point decrease in NIH Stroke Scale score at 7 days. Secondary endpoints: infarct volume and modified Rankin Scale (mRS) at 3 months.

Main Results:

  • No significant difference in the primary endpoint between atorvastatin and placebo groups.
  • Similar infarct volumes were observed in both groups.
  • A trend towards better functional outcomes (mRS < 2 at 3 months) was noted in the atorvastatin group, particularly in patients with mild strokes (NIHSS ≤10).

Conclusions:

  • High-dose atorvastatin did not demonstrate short-term efficacy in the acute phase of ischemic stroke.
  • A potential favorable functional outcome at 3 months in mild stroke patients warrants further investigation in future trials.